Pharmacologically active compounds in the environment and their chirality.
about
Electric-field-induced assembly and propulsion of chiral colloidal clustersChiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.Self-assembly of folic acid: a chiral-aligning medium for enantiodiscrimination of organic molecules in an aqueous environment.Structure-guided RP-HPLC chromatography of diastereomeric α-helical peptide analogs substituted with single amino acid stereoisomersAnti-scarring properties of different tryptophan derivativesCharacterization, crystallization and preliminary X-ray diffraction analysis of an (S)-specific esterase (pfEstA) from Pseudomonas fluorescens KCTC 1767: enantioselectivity for potential industrial applications.Risk-based prioritization of pharmaceuticals in the natural environment in Iraq.Chromatographic Studies of Protein-Based Chiral Separations.RESOLUTION OF R-(-) AND S-(+)- ENANTIOMERS OF CLENBUTEROL IN PHARMACEUTICAL PREPARATIONS AND BLACK MARKET PRODUCTS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.Differential pharmacologic properties of the two C75 enantiomers: (+)-C75 is a strong anorectic drug; (-)-C75 has antitumor activity.Ruthenium(II) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.Synthesis of Novel Chiral Sulfonamide-Bearing 1,2,4-Triazole-3-thione Analogs Derived from D- and L-Phenylalanine Esters as Potential Anti-Influenza Agents.Ecotoxicological evaluation of propranolol hydrochloride and losartan potassium to Lemna minor L. (1753) individually and in binary mixtures.Chiral platinum (II)-4-(2,3-dihydroxypropyl)- formamide oxo-aporphine (FOA) complexes promote tumor cells apoptosis by directly targeting G-quadruplex DNA in vitro and in vivo.Effects of chirality on the antifungal potency of methylated succinimides obtained by Aspergillus fumigatus biotransformations. comparison with racemic ones.First chemoenzymatic stereodivergent synthesis of both enantiomers of promethazine and ethopropazine.Distinct enantiomeric signals of ibuprofen and naproxen in treated wastewater and sewer overflow.Distribution, mass load and environmental impact of multiple-class pharmaceuticals in conventional and upgraded municipal wastewater treatment plants in East China.Enantiomeric fraction determination of 2-arylpropionic acids in a package plant membrane bioreactor.Colorimetric enantiorecognition of oligopeptide and logic gate construction based on DNA aptamer-ligand-gold nanoparticle interactions.Enantioselective transformation of fluoxetine in water and its ecotoxicological relevance.Enantiomer-specific in vitro biotransformation of select pharmaceuticals in rainbow trout (Oncorhynchus mykiss).Chiral Phosphate in Rhodium-Catalyzed Asymmetric [2+2+2] Cycloaddition: Ligand, Counterion, or Both?Chirality in adsorption on solid surfaces.Enantioselective analysis of non-steroidal anti-inflammatory drugs in freshwater fish based on microextraction with a supramolecular liquid and chiral liquid chromatography-tandem mass spectrometry.Resolution of Rac-Bambuterol via Diastereoisomeric Salt Formation with o-Chloromandelic Acid and Differences in the Enantiomers' Pharmacodynamical Effects in Guinea Pigs and Beagles.Chromatographic enantioseparation by poly(biphenylylacetylene) derivatives with memory of both axial chirality and macromolecular helicity.Surface-mounted MOF templated fabrication of homochiral polymer thin film for enantioselective adsorption of drugs.Simultaneous enantiomeric analysis of pharmacologically active compounds in environmental samples by chiral LC-MS/MS with a macrocyclic antibiotic stationary phase.Solid-phase extraction combined with dispersive liquid-liquid microextraction and chiral liquid chromatography-tandem mass spectrometry for the simultaneous enantioselective determination of representative proton-pump inhibitors in water samples.Multi-residue enantiomeric analysis of human and veterinary pharmaceuticals and their metabolites in environmental samples by chiral liquid chromatography coupled with tandem mass spectrometry detection.Multi-residue enantiomeric analysis of pharmaceuticals and their active metabolites in the Guadalquivir River basin (South Spain) by chiral liquid chromatography coupled with tandem mass spectrometryOccurrence of Illicit Drugs in Surface Water and Wastewater in the UKEnantioselective HPLC analysis and biodegradation of atenolol, metoprolol and fluoxetine
P2860
Q27324244-696A070B-6876-42A0-BC7C-0DA4A3F660C9Q33851532-EA0DD3CA-1D60-4633-99E4-2055EE930D8AQ34357590-AD253C61-EA90-40B9-93EB-100446C5D3DEQ35017565-37D162C4-1E26-43E9-AEC3-E34248806E90Q35122999-231D1A73-9454-4CAD-B6AD-C02B3F4ADB01Q36448234-43027176-749F-4836-9A76-0D4EB66A1C0AQ37116450-212156E9-46E1-4604-A94C-825F7F866C64Q37718776-7DDADBD5-57BD-4F89-814F-1325F240437AQ38600837-E3DF05D1-D8DC-4635-991B-890808B33CB1Q39091680-EB275110-CA5F-41A6-9B00-70454033B06DQ39160101-9A25B8B2-D0F0-43BE-A2E4-24DE7EF5D857Q39236976-89F61B39-6D1F-4B9B-AAB9-3D6F36AD2B21Q39736217-89860BA5-1646-4D83-ACE5-63743C51DAE0Q41109766-5EC0FB60-933B-46CE-88C1-8866905DDD1BQ42365313-FCC8C2CB-0544-483B-B298-05B6EE97D05FQ42711233-18EB192D-A685-40F2-8FE5-74CF7928FB58Q43109663-1B871B44-ABBF-45C1-BADA-A6A6D368B197Q43327342-8020DFD7-A481-4768-A8B5-88FD5204EB80Q43328604-AE104603-5694-44A2-AB18-B5E80288935FQ43961618-26B8F646-30BF-4277-9768-5C6F0991C106Q44579684-878D9405-9A5F-4A6D-9268-4756B494CE66Q44933833-5E1EEA6F-038C-401E-943A-4BB7FBAC778AQ45794012-9C9636C5-080C-4091-A523-C8B9B5E3CDE2Q46550066-3013C0E5-1F7A-4716-907E-51C2D87C0D36Q46708783-C3E07FE0-0398-4171-A2A2-90F9CE217C8DQ46744273-C52942C8-284E-42FF-B968-214EDD55889DQ46919229-E9C80B80-B26A-4A80-BAD4-58EA1ABB7C7BQ48333260-147E6386-D462-4ADA-8607-9B99E562B391Q48348221-172F7E25-C93E-4737-91AE-0BCAF952EBDCQ48376380-DAC9B8E6-4728-4772-B655-30AA15710BB4Q51236069-A37F16A6-739A-4CCF-96C3-904989236FEFQ53487605-F924B978-A974-4CF6-90FA-3ABA0EC8C7B8Q57237582-1552C194-4D3D-43BE-977D-76CEB87A60F1Q58309034-F322C880-6082-465E-A57D-D165B78565A6Q58875575-1B696471-E797-4DAF-8800-7EFD8A930BF0
P2860
Pharmacologically active compounds in the environment and their chirality.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacologically active compounds in the environment and their chirality.
@en
Pharmacologically active compounds in the environment and their chirality.
@nl
type
label
Pharmacologically active compounds in the environment and their chirality.
@en
Pharmacologically active compounds in the environment and their chirality.
@nl
prefLabel
Pharmacologically active compounds in the environment and their chirality.
@en
Pharmacologically active compounds in the environment and their chirality.
@nl
P2860
P356
P1476
Pharmacologically active compounds in the environment and their chirality
@en
P2093
Barbara Kasprzyk-Hordern
P2860
P304
P356
10.1039/C000408C
P577
2010-09-20T00:00:00Z